{"url_path":"/sec/dgx/8-k/2026-05-08/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1022079/0001104659-26-057938-index.html","accession_number":"0001104659-26-057938","cik":"0001022079","ticker":"DGX","issuer_name":"QUEST DIAGNOSTICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1022079/0001104659-26-057938-index.html","primary_entity_key":"0001022079","primary_entity_name":"QUEST DIAGNOSTICS INC"},"word_count":178,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits**\n\n \n\n \n**Exhibit**\n**Description**\n\n \n \n \n\n \n[4.1](https://www.sec.gov/Archives/edgar/data/1022079/000094787101500290/ex4-3_062801.txt)\n[Indenture dated as of June 27, 2001, among the Company, the Subsidiary Guarantors and the Trustee (filed as an Exhibit to the Company’s current report on Form 8-K (Date of Report: June 27, 2001) and incorporated herein by reference)](https://www.sec.gov/Archives/edgar/data/1022079/000094787101500290/ex4-3_062801.txt)\n\n \n \n \n\n \n[4.2*](tm2613096d2_ex4-2.htm)\n[Twenty-Fourth Supplemental Indenture, dated as of May 6, 2026, between the Company and the Trustee](tm2613096d2_ex4-2.htm)\n\n \n \n \n\n \n[4.3*](tm2613096d2_ex4-2.htm)\n[Form of the Company’s 5.000% Senior Note due 2036 (incorporated by reference from Exhibit A to Exhibit 4.2 hereof)](tm2613096d2_ex4-2.htm)\n\n \n \n \n\n \n[5.1*](tm2613096d2_ex5-1.htm)\n[Opinion of Allen Overy Shearman Sterling US LLP, counsel to the Company](tm2613096d2_ex5-1.htm)\n\n \n \n \n\n \n[23.1*](tm2613096d2_ex5-1.htm)\n[Consent of Allen Overy Shearman Sterling US LLP (included in Exhibit 5.1)](tm2613096d2_ex5-1.htm)\n\n \n \n \n\n \n104*\nThe cover page from this current report on Form 8-K, formatted in Inline XBRL.\n\n \n\n*        Filed herewith.\n\n \n\n2\n\n \n\n \n\n**Signature**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.\n\n \n\nMay 8, 2026\n\n \n\n \nQUEST DIAGNOSTICS INCORPORATED\n\n \n \n \n\n \nBy:\n/s/ Sean D. Mersten\n\n \n \nSean D. Mersten\n\n \n \nVice President and Corporate Secretary"}